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Background:  Meniscal  substitutes  have  been  suggested  for  the  treatment  of  knee pain  after  partial  menis-
cectomy.  However,  despite  the  partial  nature  of the  initial  meniscectomy,  secondary  extrusion  of  the
substitute  is  common.  The  primary  objective  of  this  study  was  to evaluate  morphological  outcomes  of
meniscal  substitute  implantation  and  their potential  associations  with preoperative  meniscal  extrusion.
Hypothesis:  Preoperative  absolute  meniscal  extrusion  in  the coronal  plane  predicts  poorer  morphological
and  clinical  outcomes.
Material and  methods:  Consecutive  patients  who  received  an  Actiﬁt® meniscal  substitute  between  2008
and  2011 were  included  prospectively.  After  1 year  and  2 years,  the IKDC  score  and  KOOS  were  deter-
mined  and  magnetic  resonance  imaging  performed.  The  morphological  evaluation  consisted  in measuring
meniscal  extrusion  and  cartilage  coverage  by  the substitute  in  the  coronal  and sagittal  planes.
Results:  Twenty  patients  were  included.  Among  them,  3 required  subsequent  removal  of the  substitute.
The  mean  subjective  IKDC  score  increased  from  48.1  preoperatively  to  56.4  after  2  years.  Over  the  same
period,  the  function/sports/recreational  activities  component  of  the  KOOS  improved  signiﬁcantly  (42.9  vs.
55.0,  P = 0.04).  Positive  correlations  between  preoperative  and  1-year  values  were  demonstrated  for  both
cartilage  coverage  in the  coronal  and  the  sagittal  planes  (P = 0.03  and  P = 0.04,  respectively)  and  coronal
absolute  meniscal  extrusion  (P = 0.05).  No  signiﬁcant  differences  were  found  between  preoperative  and
2-year  values  of cartilage  coverage  in the  coronal  and sagittal  planes  (P  =  0.38).  There  was  a  negative
correlation  linking  preoperative  meniscal  extrusion  in  the coronal  plane  to 1-year  cartilage  coverage
in  the  coronal  and  sagittal  planes  (P =  0.01  and  P  =  0.04,  respectively).  Preoperative  absolute  meniscal
extrusion  in the  coronal  plane  correlated  negatively  with  the subjective  IKDC  score  after  1 year  (P  =  0.02).
Discussion: Preoperative  meniscal  extrusion  in the  coronal  plane  strongly  predicts  clinical  and  morpho-
logical  outcomes.  Marked  preoperative  meniscal  extrusion,  even  in  a patient  with  symptoms  after  partial
meniscectomy,  should  prompt  an appraisal  of whether  allograft  replacement  may  be more  appropriate
than  a meniscal  substitute.
Level of evidence:  IV,  prospective  study.
© 2015  Elsevier  Masson  SAS.  All  rights  reserved.. IntroductionThe approach to meniscal lesions has changed in response to
ew knowledge on meniscal functions, which are now known
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877-0568/© 2015 Elsevier Masson SAS. All rights reserved.to include load distribution, improved joint congruity, shock
absorption, knee stabilisation (most notably after an anterior cru-
ciate ligament [ACL] tear), lubrication, and proprioception [1].
To spare meniscal tissue and prevent medium- or long-term
osteoarthritis, increasing emphasis is now placed on minimising
the amount of meniscal tissue removed and on repairing meniscal
lesions whenever possible. Nevertheless, patients with extensive
irreparable lesions may  undergo total or subtotal meniscectomy,
which carries a risk of long-term osteoarthritis [2,3].
Meniscal substitutes were introduced to treat patients with
knee pain after partial meniscectomy. In theory, the prerequisites
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or meniscal substitute implantation are an intact meniscal rim
nd presence of the anterior and posterior meniscal horns. The
rst substitute used in human patients was the Collagen Meniscus
mplant (CMI, Menaﬂex®, ReGen Biologics, Hackensack, NJ, USA),
hich was introduced in the 1990s. This substitute made of bovine
chilles-tendon type I collagen was proven effective in alleviat-
ng pain and in allowing the resumption of physical activities in
he short and medium terms [4–8]. Furthermore, ingrowth of host
eniscal tissue was demonstrated [9]. However, the use of bovine
ollagen carries a risk of infectious disease transmission and aller-
ic reactions [10]. In addition, once moistened, the CMI  is fragile,
aising challenges with implant positioning and ﬁxation. Actiﬁt®
Orteq, London, UK) is a recently developed, synthetic implant
ade of biodegradable polyurethane. Proof has been obtained that
his implant relieves pain in the short term [11–15] and serves as a
upport for the ingrowth of host meniscus-like tissue [15]. Despite
eports by Zaffagnini et al. [7] and Monllau et al., [8] that meniscal
mplants may  prevent osteoarthritic changes, this effect remains
o be proven. Extrusion of the meniscus or substitute decreases
artilage coverage, a factor that contributes to protect the carti-
age. Marked extrusion (> 3 mm)  of the native meniscus measured
y non-weight-bearing magnetic resonance imaging (MRI) is func-
ionally equivalent to a meniscectomy [3] and correlates with the
isk of osteoarthritis. Similarly, De Coninck et al. [16] reported that
edial Actiﬁt® implantation was followed by a signiﬁcant increase
n absolute meniscal extrusion (aME) in the coronal plane, which
ecreased the extent of cartilage coverage.
The objectives of this study were to assess both overall cartilage
overage and Actiﬁt® extrusion in the coronal and sagittal planes
nd to determine whether these factors were associated with pre-
perative extrusion of the residual native meniscus. The study
ypothesis was that preoperative meniscal extrusion in the coro-
al plane predicted poorer morphological and clinical outcomes of
ctiﬁt® implantation.
. Material and methods
.1. Inclusion
Consecutive patients who underwent Actiﬁt® implantation
etween 2008 and 2011 at the Versailles hospital centre (Le Ches-
ay, France) were included prospectively. The inclusion criteria
ere aged 18 to 50 years, post-meniscectomy syndrome in a stable
r stabilised knee, and absence of ICRS-grade 3 or treated chondral
esions. Partial meniscectomy was also required, with visibility by
agnetic resonance imaging (MRI) or computed tomography (CT)
f the meniscal rim and of the anterior and posterior horns. Finally,
atients were not included if they had osteoarthritis grade 2 or
igher in the Albäck classiﬁcation based on comparative schuss
iews and/or axial misalignment greater than 5◦.
.2. Operative technique
The patient was in the supine position, with a pneumatic
ourniquet. The procedure was performed via the anteromedial
r anterolateral arthroscopic approach. Damage to the meniscus
nd cartilage was assessed. Any unstable meniscal fragments were
xcised to obtain a regular meniscal cut in a well-vascularised area.
 ruler was used to measure the length of the meniscal defect, and
he substitute was cut to 110% of that length. After implantation of
he substitute, ﬁxation started with a horizontal all-inside suture
t the posterior segment/substitute junction, using Fast-Fix (Smith
 Nephew, London, UK). The remainder of the substitute was  then
utured from posterior to anterior, and any anterior excess wasFig. 1. Healthy meniscus: measurements of absolute meniscal extrusion (aME) in
the coronal plane (1.6), relative meniscal extrusion (1.6/[1.6 + 5.9]), and coronal
cartilage coverage index (5.9/33.3).
trimmed to ensure a perfect ﬁt. If needed, same-stage ACL recon-
struction or a procedure on the cartilage was performed.
2.3. Postoperative rehabilitation
The patients wore a knee extension splint for 4 weeks and
refrained from weight bearing for 6 weeks. Flexion was limited
to 60◦ for 4 weeks then to 90◦ for the next 2 weeks before being
allowed without restriction. Isometric quadriceps exercises were
started 2 days after the surgical procedure.
2.4. Assessment method
Clinical outcomes after 1 and 2 years were assessed based
on the clinical KOOS [17] and on the subjective and objective
IKDC scores [18]. T2-weighted MRI  sequences were read by an
independent experienced observer using a Picture Archiving and
Communication System (PACS, Centricity, General Electric Health-
care, Milwaukee, WI,  USA). Preoperative and postoperative aME
[19] was measured on the coronal view through the centre of the
tibiofemoral compartment, as the greatest distance (in mm)  from
the meniscal margin to the tibial margin, excluding any osteo-
phytes. On the same view, the percentage of meniscal extrusion
[20,21] or relative meniscal extrusion (rME) was determined as
the ratio of aME  over total meniscus size in the coronal plane
(Fig. 1). Preoperatively, this same view served to measure the
width of the residual meniscal rim. Sagittal views through the
centre of the tibiofemoral compartment (determined by count-
ing the number of slices through this compartment then selecting
the middle slice) were used to measure extrusion of the anterior
segment (antME) as the distance between the anterior meniscal
margin and anterior tibial cartilage margin (Fig. 2) and extrusion
of the posterior segment (postME) (Fig. 3) [22] as the distance
between the posterior meniscal margin and posterior tibial car-
tilage margin. Finally, these same coronal and sagittal slices were
used to assess the coronal cartilage coverage index (cCCI) (Fig. 4),
deﬁned as the percentage of tibial cartilage covered by the menis-
cus (ratio of tibial cartilage covered by the meniscus over total tibial
cartilage). These measurements showed good inter-observer and
intra-observer reproducibility in an earlier study [23].
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Fig. 2. Healthy meniscus: measurement of extrusion of the anterior meniscal seg-
ment  (antME, 3 mm).
Fig. 3. Healthy meniscus: measurement of extrusion of the posterior meniscal seg-
ment (postME, 4.2 mm).
Fig. 4. Healthy meniscus: measurement of the sagittal cartilage coverage index
(sCCI) ([5.9 + 10.2]/34.5).
Fig. 5. Extruded lateral Actiﬁt® substitute, grade I signal.Fig. 6. Medial Actiﬁt® substitute with no extrusion, grade II signal.
On postoperative T2-weighted MRI  scans, the signal from the
substitute was graded as described by Génovèse et al. [24] (grade I,
high signal; grade II, intermediate signal; and grade III, low signal
similar to that from the healthy meniscus) (Figs. 5–7).
2.5. Statistical analysis
A descriptive analysis of all the study data was performed.
Continuous variables were described as mean (±SD) if normally
distributed and as median (interquartile range) otherwise. Cate-
gorical variables were described as n (%). For comparisons of mean
values across operative techniques, Student’s t test was used if the
underlying assumptions were met  and the non-parametric Fisher’s
test otherwise. Similarly, percentages were compared using the
Chi2 test if applicable and the non-parametric Wilcoxon test if not.
Variables of P < 0.05 (one-sided test) were considered signiﬁcant.
3. Results
The study included 20 patients with a mean age of 28.7 years.
The substitute was  implanted in the lateral compartment in 12
patients and the medial compartment in 8 patients. Additional
procedures consisted of ligament reconstruction in 4 patients
and cartilage procedures in 3 patients (mosaicplasty in 1 and
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Fig. 7. Lateral Actiﬁt® substitute without posterior extrusion, grade II signal.
Fig. 8. Patient ﬂow chart.
Table 1
Mean values of the clinical scores.
Preoperative 1 year 2 years P-value (preoperative
vs. 2 years)
IKDC sub. 48.1 59 56.4 0.16
IKDC ob.
A/B/C/D 3/6/6/3 7/5/4/1 4/3/8/2
KOOS s. 67.6 73 71.5 0.38
KOOS pn. 58.2 72.6 68.8 0.31
KOOS dl. 67.2 77.7 74.5 0.57
KOOS sr. 42.9 52 55 0.04
KOOS qol. 36.5 46.8 51.9 0.07
s
a
d
s
t
ﬁ
r
y
a
s
Fig. 9. Objective IKDC score.ub.: subjective; ob.: objective; s.: symptoms; pn.: pain; dl.: daily living; sr.: sports
nd recreational activities; qol.: quality of life.
ebridement in 2). Mean knee pain duration was  2 years; time
ince meniscectomy was longer than 2 years in only 3 patients. Of
he 20 patients, 2 (10%) were lost to follow-up and 3 were classi-
ed as treatment failures after 2 years, with failure deﬁned as any
evision procedure to remove all or part of the substitute (Fig. 8).
Of the remaining 15 patients, 14 underwent MRI  after 1 and 2
ears and 1 was re-evaluated without MRIs. Results were expressed
ccording to the intention-to-treat approach.
Table 1 and Fig. 9 report the clinical outcomes. The mean
ubjective IKDC score increased from 48.1 preoperatively to 59.0Fig. 10. Correlation between preoperative and 1-year values of coronal absolute
meniscal extrusion (aME).
after 1 year and 56.4 after 2 years (P > 0.05). For the KOOS, only
the function/sports/recreational activities component was signiﬁ-
cantly improved after 2 years (42.9 vs. 55.0, P = 0.04).
Table 2 shows the morphological outcomes. No signiﬁcant dif-
ferences were found between preoperative and 2-year values of
cartilage coverage in the coronal or sagittal planes (9.8% vs. 9.6%,
P = 0.84; and 31.9% vs. 28.9%, P = 0.38; respectively). Mean preop-
erative width of the meniscal rim was  6.2 mm;  this variable did
not correlate signiﬁcantly with coronal aME  after 1 year or 2 years
(P = 0.68 and P = 0.89, respectively) or with any of the clinical scores
after 1 or 2 years.
Preoperative coronal aME  was signiﬁcantly greater compared
to a population with normal menisci [23] (2.7 mm vs. 1.09 mm,
P < 0.001). Of the 14 patients, 7 had a preoperative coronal aME
> 3 mm.  The groups with preoperative coronal aME  ≤ 3 mm vs.
> 3 mm were not signiﬁcantly different regarding the preoper-
ative and postoperative clinical scores and MRI data (Table 3).
Postoperative coronal aME  was  not signiﬁcantly different between
the groups with medial and lateral substitutes (P = 0.89). Posterior
segment extrusion increased signiﬁcantly from the preoperative
measurement to the measurements after 1 and 2 years (P = 0.05
and P = 0.02). Coronal aME  extrusion increased signiﬁcantly from
the preoperative time point to the 1-year time point (P = 0.009).
Positive correlations between preoperative and 1-year values
were found for the following variables: coronal cartilage cover-
age (P = 0.03), sagittal cartilage coverage (P = 0.04), and coronal aME
(P = 0.05) (Fig. 10). The preoperative and 2-year values of these same
three variables showed no signiﬁcant correlations.
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Table  2
Morphological outcomes.
Preoperative (n = 14) 1 year
(n = 14)
2 years
(n = 14)
P-value (preoperative
vs. 1 year)
P-value (preoperative
vs. 2 years)
aME  2.7 mm 4 mm 3.4 mm 0.009 0.35
rME  48% 61.5% 55.7% 0.08 0.19
cCCI  9.9% 8.9% 9.6% 0.81 0.73
antME 4.9 mm 5.6 mm 5.7 mm 0.23 0.52
postME 1.8 mm 4.8 mm 3.2 mm 0.05 0.02
sCCI  31.9% 24.4% 28.9% 0.04 0.38
aME: absolute meniscal extrusion; rME: relative meniscal extrusion; cCCI: coronal cartilag
extrusion; sagittal cartilage coverage index.
Fig. 11. Correlation between preoperative coronal absolute meniscal extrusion
(aME) and IKDC score after 1 year.
Table 3
Clinical scores determined preoperatively and after 2 years: comparison of patients
whose preoperative coronal absolute meniscal extrusion was > 3 mm or ≤ 3 mm.
Preoperative
extrusion ≤
3 mm
n = 7
Preoperative
extrusion >
3 mm
n = 7
P-value
Preoperative objective IKDC 44.8 44 0.64
Preoperative mean KOOS 43.5 53.86 0.18
2-year objective IKDC 68.2 49.5 0.37
a
a
s
s
2
c
t
g
I
g
4
a
m
P2-year mean KOOS 75.3 59.8 0.11
2-year absolute coronal extrusion 3.88 mm 3.47 mm 0.39
Negative correlations were found linking preoperative coronal
ME  to 1-year values of both coronal and sagittal cartilage cover-
ge (P = 0.01 and P = 0.04, respectively) and to the subjective IKDC
core after 1 year (P = 0.02) (Fig. 11). For these same variables, no
igniﬁcant correlations were observed between preoperative and
-year values. In addition, preoperative cartilage coverage in the
oronal or sagittal plane did not correlate signiﬁcantly with any of
he clinical scores after 1 year or 2 years.
After 1 year, of the 14 patients with MRIs, 8 had grade II and 6
rade I MRI  signal from the substitute. After 2 years, the grade was
I in 10 cases and I in 4 cases (Figs. 5–7). No substitutes generated
rade III signal.
. DiscussionOur study provides objective evidence that the characteristics of
 meniscus after partial meniscectomy differ from those of a “nor-
al” meniscus that would be merely missing its central portion.
reoperative coronal aME  was signiﬁcantly increased comparede coverage index; antME: anterior meniscal extrusion; postME: posterior meniscal
to normal menisci [23] (P < 0.001) and close to the 3-mm cut-off
reported in the literature (2.7 mm).  Similarly, De Coninck et al. [16]
reported abnormal preoperative meniscal extrusion, which was
greatest for the lateral meniscus (3.42 mm).  This ﬁnding indicates
that the post-meniscectomy osteoarthritic process is dependent
not only on the amount of meniscal tissue removed [25], but also
on extrusion of the residual meniscus, which further diminishes the
amount of effective meniscal tissue interposed between the femur
and tibia (functional meniscectomy concept).
De Coninck et al. [16] showed that Actiﬁt® substitute implan-
tation into the medial compartment was  followed by a signiﬁcant
increase in coronal aME. Our study conﬁrms this ﬁnding. One  possi-
ble explanation is that substitute implantation requires additional
meniscal trimming, which further loosens the meniscal belt.
Actiﬁt® substitute implantation does not increase cartilage cov-
erage. Rodkey et al. [9] performed follow-up arthroscopy 1 year
after CMI  implantation in 141 patients and found that 65% to
76% of the post-meniscectomy defect was  ﬁlled. Studies involving
medium-term MRI  assessments of substitutes consistently showed
a decrease in size [4–6,7,8,13,24]. In addition, because of the extru-
sion, the supplemental meniscal tissue provided by the substitute
is not in the normal position between the tibial plateau and the
femoral condyle. The combination of shrinkage and extrusion of
the substitute results in failure to increase cartilage coverage. When
treatment failure is deﬁned as any revision procedure to remove all
or part of the substitute, the failure rate of Actiﬁt® implantation is
15% (3/20) after 2 years.
Substitute implantation is classically indicated in patients with
knee pain after partial meniscectomy, presence of both meniscal
horns, a sufﬁciently wide meniscal rim, and no osteoarthritis. In our
study, greater width of the residual meniscal rim correlated neither
with better clinical outcomes nor with increased cartilage coverage.
The main predictor of clinical and morphological outcomes after
substitute implantation was  the amount of preoperative coronal
aME. Marked preoperative coronal aME  correlated with limited car-
tilage coverage in the coronal and sagittal planes and with poorer
clinical outcomes after 1 year.
The results of our study are consistent with those reported pre-
viously. In a study by Bouyarmane et al. [14], mean IKDC after 2
years was 66.97 ± 18.34. Hirschmann et al. [26,27] found that most
patients were IKDC A or B 1 year after CMI  implantation but that the
IKDC scores after 2 years were decreased compared to a same-age
healthy population (56.4 vs. 88.9) [26].
The small sample size is a limitation of our study. Thus, the
statistical power was not sufﬁcient to determine the preoperative
coronal aME  cut-off above which clinical outcomes were poorer.
The other study limitation is the short follow-up, of only 2 years.
5. ConclusionActiﬁt® substitute implantation does not increase cartilage cov-
erage by meniscal tissue. Filling of the meniscal defect is offset by
increased extrusion in the coronal and sagittal planes. Preoperative
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oronal aME  strongly predicts postoperative clinical and morpho-
ogical outcomes. Therefore, absence of such extrusion should be
dded to the criteria used to select patients for substitute implan-
ation. In patients with post-partial-meniscectomy syndrome and
 sufﬁciently thick meniscal rim, the possibility that a meniscal
llograft may  be more appropriate than a substitute should be con-
idered.
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